You just read:

New Phase 3 Data Show Single Dose Of STELARA® (ustekinumab) Induces Clinical Remission And Response In Adults With Moderate To Severe Ulcerative Colitis

News provided by

Janssen Pharmaceutical Companies of Johnson & Johnson

Oct 09, 2018, 08:07 ET